GEN1E LIFESCIENCES INC., 2025-12-29
An SEC Form D private-offering notice from Palo Alto, CA, a $11,887,377 filer-stated offering target in Biotech. Filed 2025-12-29. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing AI-driven precision immunomodulatory therapies for inflammatory and rare diseases, including a Phase 2 program for ARDS and a Duchenne Muscular Dystrophy candidate.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Phenomix Sciences, Inc., 2025-12-29, $5M, Menlo Park, CA
- Greater Good Healthcare Inc., 2025-12-29, $20.6M, El Segundo, CA
- Glycologix, Inc., 2025-12-29, $1M, Beverly, MA
- Aqua Heart Inc, 2025-12-29, $6M, Santa Ana, CA
- Aprea Therapeutics, Inc., 2025-12-29, $5.8M, Doylestown, PA
- Tivic Health Systems, Inc., 2025-12-29, $16.3M, Fremont, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.